To embed, copy and paste the code into your website or blog:
A new year, a new administration in the United States, and new cartel enforcement leadership in the United Kingdom have begun. In the United States, first-of-their-kind criminal charges have been brought involving labor and wages in an industry that had previously been largely untouched by cartel prosecutors. Federal legislation will now protect whistleblower employees, thereby encouraging them to report on their company’s anticompetitive conduct. A lot has happened since we last caught up on developments in cartel enforcement. Big changes are expected. Trillions of dollars are proposed to be spent by the federal government in the name of pandemic relief, just as the U.S. Department of Justice (DOJ) has begun bringing criminal charges through its Procurement Collusion Strike Force. Let’s catch up.
NSA: Foreign-Language Trainer Civil Penalty in Fraud Case natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
In this Issue:
United States
1.
FTC to study impact of physician group and health care facility mergers.
As part of its Merger Retrospective Program, on Jan. 13, 2021, the FTC issued an Order to File a Special Report to six health insurance companies. The FTC plans to use information gathered through the Special Report (e.g., patient-level data from 2015 to 2020) to analyze the competitive impact of physician and health care facility consolidation, as well as mergers and acquisitions, in markets for health care services.
2. FTC approves final order imposing conditions on combination of Pfizer Inc.’s Upjohn and Mylan N.V.
On Jan. 28, 2021, the FTC announced its final order approving the combination of the Upjohn division of Pfizer Inc. and Mylan N.V. in a spinoff, forming Viatris Inc. The FTC alleged that the proposed acquisition would harm competition in generic drug markets. The final order requires the parties to divest certain rights and assets in seven current generic
Friday, February 5, 2021
FTC to study impact of physician group and health care facility mergers
FTC approves final order imposing conditions on combination of Pfizer Inc.’s Upjohn and Mylan N.V.
As part of its Merger Retrospective Program, on Jan. 13, 2021, the FTC issued an Order to File a Special Report to six health insurance companies. The FTC plans to use information gathered through the Special Report (e.g., patient-level data from 2015 to 2020) to analyze the competitive impact of physician and health care facility consolidation, as well as mergers and acquisitions, in markets for health care services.
On Jan. 28, 2021, the FTC announced its final order approving the combination of the Upjohn division of Pfizer Inc. and Mylan N.V. in a spinoff, forming Viatris Inc. The FTC alleged that the proposed acquisition would harm competition in generic drug markets. The final order requires the parties to divest certain rights and assets in seven current generic drug